fingolimod hydrochloride has been researched along with Cancer of Stomach in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Feng, Y; Wang, Y; Zhang, W; Zhou, R | 1 |
| Chen, X; Jiang, H; Liang, Y; Liu, L; Meng, X; Pan, S; Song, X; Wang, J; Yin, D; Zheng, T | 1 |
2 other study(ies) available for fingolimod hydrochloride and Cancer of Stomach
| Article | Year |
|---|---|
Protein Phosphatase 2a Inhibits Gastric Cancer Cell Glycolysis by Reducing MYC Signaling.
Topics: Cell Line, Tumor; Cell Proliferation; Fingolimod Hydrochloride; Glycolysis; Humans; Protein Phosphatase 2; Proto-Oncogene Proteins c-myc; Signal Transduction; Stomach Neoplasms | 2023 |
PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Fingolimod Hydrochloride; G1 Phase; Humans; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Propylene Glycols; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction; Sphingosine; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2010 |